NASDAQ: REFR

RESEARCH FRONTIERS INC

CIK 0000793524 · SIC 6794 · Patent Owners & Lessors

Micro Revenue $1M Assets $2M as of Aug 30, 2026

Information included in this Annual Report on Form 10-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future… About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (DLTH 10-Q) is open in full — no account needed.

10-Q Filed Aug 6, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jun 12, 2026 · Period ending Jun 11, 2026

Summary not yet generated.

Partner

Trade REFR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 5, 2026 · Period ending Jun 2, 2026 Red flag

Research Frontiers receives Nasdaq delisting warnings for bid price and market value failures

3 material changes detected. Sign up free to read the summary.

10-Q Filed May 8, 2026 · Period ending Mar 31, 2026

revenue $136,319, net income -$525,365. Research Frontiers revenue plunges 76% as one-time license lapses; liquidity outlook cut to 12 months

5 material changes detected. Sign up free to read the summary.

10-K/A Filed Mar 19, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Mar 5, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

8-K Filed Feb 18, 2026 · Period ending Feb 18, 2026

Summary not yet generated.

10-Q Filed Nov 6, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

8-K Filed Sep 15, 2025 · Period ending Sep 15, 2025

Summary not yet generated.

10-Q Filed May 8, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Mar 6, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 6, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

Description Six months ended June 30, 2026 Six months ended June 30, 2025 Three months ended June 30, 2026 Three months ended June 30, 2025
Fee income 222,665 689,680 86,346 129,904
Operating expenses 1,148,598 1,412,398 627,216 775,922
Research and development 274,234 331,963 128,884 169,086
Total expenses 1,422,832 1,744,361 756,100 945,008
Operating loss (1,200,167) (1,054,681) (669,754) (815,104)
Net interest income 14,634 25,811 9,586 11,278
Other income - 47,357 - -
Net loss (1,185,533) (981,513) (660,168) (803,826)
Basic and diluted net loss per common share (0.03) (0.03) (0.02) (0.02)
Weighted average number of common shares outstanding 34,513,740 33,648,221 34,867,786 33,648,221

Condensed Consolidated Balance Sheets

Description June 30, 2026 December 31, 2025
(Unaudited)
Assets
Current assets:
Cash and cash equivalents 1,087,956 664,299
Royalties receivable, net of reserves of $1,534,850 and $1,384,850, respectively 207,955 408,666
Prepaid expenses and other current assets 159,730 70,969
Total current assets 1,455,641 1,143,934
Fixed assets, net 2,867 3,393
Operating lease ROU assets 960,989 1,048,352
Deposits and other assets 56,066 56,066
Total assets 2,475,563 2,251,745
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of operating lease liability 152,960 146,043
Accounts payable 135,206 132,666
Deferred revenue 69,068 -
Accrued expenses 53,651 19,168
Total current liabilities 410,885 297,877
Operating lease liability, net of current portion 941,585 1,020,242
Total liabilities 1,352,470 1,318,119
Shareholders’ equity:
Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 34,867,786 in 2026 and 33,648,221 in 2025 3,487 3,365
Additional paid-in capital 129,926,946 128,552,068
Accumulated deficit (128,807,340) (127,621,807)
Total shareholders’ equity 1,123,093 933,626
Total liabilities and shareholders’ equity 2,475,563 2,251,745

Condensed Consolidated Statements of Cash Flows (Unaudited)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net loss (1,185,533) (981,513)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 631 6,166
Share-based compensation - 175,204
Credit loss expense 150,000 124,253
ROU asset amortization 87,363 86,925
Change in assets and liabilities:
Royalty receivables 50,711 (2,413)
Prepaid expenses and other assets (88,761) (67,791)
Accounts payable and accrued expenses 37,023 (68,297)
Deferred revenue 69,068 71,563
Operating lease liability (71,740) (63,798)
Net cash used in operating activities (951,238) (719,701)
Cash flows from investing activities:
Purchases of fixed assets (105) (209)
Net cash used in investing activities (105) (209)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants 1,375,000 -
Net cash provided by financing activities 1,375,000 -
Net increase (decrease) in cash and cash equivalents 423,657 (719,910)
Cash and cash equivalents at beginning of period 664,299 1,994,186
Cash and cash equivalents at end of period 1,087,956 1,274,276

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About RESEARCH FRONTIERS INC

Source: Item 1 (Business) from the 10-K filed March 5, 2026. Description as filed by the company with the SEC.

ITEM
1.
BUSINESS

Forward-Looking
Statements

Information
included in this Annual Report on Form 10-K may contain forward-looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning
future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,”
“anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements. Such
forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which
are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different
from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks, uncertainties
and factors include, but are not limited to, those factors set forth in this Annual Report on Form 10-K under “